Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Response to Celecoxib in Healthy Volunteers
NCT02413203Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pain and inflammation comparing Celecoxib with Placebo (2 arms). Primary endpoints: Prostaglandin E2 at 4 hours, Prostaglandin F2a at 4 hours and 2 more. Started Mar 2015; status: completed.
02
Drugs
celecoxib
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT02413203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02413203.